BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33181666)

  • 1. Effect of FAT1 gene expression on the prognosis of medulloblastoma in children: A protocol for systematic review and meta-analysis.
    Yu J; Gao H; Su Z; Yue F; Tian X
    Medicine (Baltimore); 2020 Nov; 99(46):e23020. PubMed ID: 33181666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mirna-21 on survival prognosis in patients with pancreatic cancer: A protocol for systematic review and meta-analysis.
    Zhang W; Chen J; He G; Xu W; He G
    Medicine (Baltimore); 2020 Aug; 99(35):e22045. PubMed ID: 32871962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenotypic detection of circulating tumor cells marked by epithelial-mesenchymal transformation on the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
    Ge B; Wang Y; Lei S; Zhang J
    Medicine (Baltimore); 2020 Oct; 99(44):e22960. PubMed ID: 33126365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between long non-coding RNA TUG1 and prognosis of patients with gastric carcinoma: A protocol for systematic review and meta-analysis.
    Xia W; Zhang Q; Li Q; Liang X
    Medicine (Baltimore); 2020 Dec; 99(49):e23522. PubMed ID: 33285765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between long non-coding RNA and prognosis of patients with coronary heart disease after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Wang F; Cai X; Jiao P; Liu Y; Yuan B; Zhang P; Liu H; Ma L
    Medicine (Baltimore); 2020 Dec; 99(51):e23525. PubMed ID: 33371075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of FAT1 is associated with overall survival in children with medulloblastoma.
    Yu J; Li H
    Tumori; 2017 Jan; 103(1):44-52. PubMed ID: 27834469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
    Zhang W; Wei L; Luo R; Liu H; Chen J
    Medicine (Baltimore); 2020 Aug; 99(33):e21483. PubMed ID: 32871993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients.
    Chen K; Huang B; Yan S; Xu S; Li K; Zhang K; Wang Q; Zhuang Z; Wei L; Zhang Y; Liu M; Lian H; Zhong C
    Aging (Albany NY); 2020 Nov; 12(21):21481-21503. PubMed ID: 33159021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.
    Fu J; Yu Q; Xiao J; Li S
    Medicine (Baltimore); 2021 Apr; 100(17):e25596. PubMed ID: 33907110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTGF expression is indicative of better survival rates in patients with medulloblastoma.
    Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG
    Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
    Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
    Ding Y; Wu W; Ma Z; Shao X; Zhang M; Wang Z
    Medicine (Baltimore); 2021 Jun; 100(22):e25964. PubMed ID: 34087839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
    Chen Z; Xiao Z; Zeng S; Yan Z
    Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
    J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers.
    Clifford SC; O'Toole K; Ellison DW
    Cell Cycle; 2009 Mar; 8(5):787. PubMed ID: 19221477
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of microRNA-203 as a biomarker for the prognosis of esophageal cancer: A protocol for systematic review and meta-analysis.
    Wang S; Yu P; Meng Z; Feng L
    Medicine (Baltimore); 2020 Dec; 99(50):e23599. PubMed ID: 33327325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
    Zhao X; Song T; He Z; Tang L; Zhu Y
    Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
    Liu L; Zhang X; Li C; Qu Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26923. PubMed ID: 34397935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
    Ren Z; Li C; Gan Y; Liu X; Liang F
    Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.